Records containing: Non-Hodgkin's Lymphoma
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2026-04-24Establishing a Tumor Bank and Initial Analysis of Germline and Tumor-Related Genetic Alterations in Families With Multiple Lymphoproliferative Malignancies
-
CLINICAL_TRIALS study record update · 2026-04-20A Phase 2 Study of Acalabrutinib With DA-EPOCH-R or R-CHOP for Patients With Untreated Diffuse Large B-cell Lymphoma
-
CLINICAL_TRIALS study record update · 2026-04-20Leukapheresis for CAR or Adoptive Cell Therapy Manufacturing
-
CLINICAL_TRIALS study record update · 2026-04-13The Prospective Collection, Storage and Reporting of Data on Patients
-
CLINICAL_TRIALS study record update · 2026-04-03A Multicenter, Open-label, Phase I/II Study to Evaluate the Safety, Efficacy, Tolerability and Pharmacokinetics of Escalating Doses of Glofitamab (RO7082859) as a Single Agent and in Combination With Obinutuzumab Administered After a Fixed, Single Dose Pre-treatment of Obinutuzumab (Gazyva®/Gazyvaro™) in Patients With Relapsed/Refractory B-cell Non-hodgkin's Lymphoma
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2026-04-03CLIC-02: A Phase I Trial of CLIC-2201 for the Treatment of Relapsed/Refractory B Cell Malignancies
-
CLINICAL_TRIALS study record update · 2026-03-20An Extension Study of Venetoclax for Subjects Who Have Completed a Prior Venetoclax Clinical Trial
-
CLINICAL_TRIALS study record update · 2026-03-03A Phase 2 Study of Response-Adapted Therapy With Copanlisib and Rituximab in Untreated Follicular Lymphoma
-
CLINICAL_TRIALS study record update · 2026-03-02Administration of Rapidly Generated EBV-Specific Cytotoxic T-Lymphocytes To Patients With EBV-Positive Lymphoma
-
CLINICAL_TRIALS study record update · 2026-02-19Phase II, Single Arm, Open Label Multi-center Study of Obinutuzumab and Ibrutinib in the Front Line Treatment of Indolent Non-Hodgkin's Lymphomas
-
CLINICAL_TRIALS study record update · 2026-02-12A First-in-Human Study of ABBV-525 (MALT1 Inhibitor) in B-Cell Malignancies
-
CLINICAL_TRIALS study record update · 2026-02-06Phase I Study of the Administration of EBV CTLs Expressing CD30 Chimeric Receptors for Relapsed CD30+ Hodgkin's Lymphoma and CD30+ Non-Hodgkin's Lymphoma (CAR CD 30)
-
CLINICAL_TRIALS study record update · 2026-01-30Expanded Access to Venetoclax
-
CLINICAL_TRIALS study record update · 2026-01-26A Phase 1 First-In-Human Study Evaluating Safety, Pharmacokinetics, and Efficacy of ABBV 291 as Monotherapy and in Combination in Non-Hodgkin's Lymphoma
-
CLINICAL_TRIALS study record update · 2026-01-15PET Imaging of Cancer Patients Using 124I-PUH71: A Pilot Study
-
CLINICAL_TRIALS study record update · 2026-01-07Phase II Study of Palifermin With Leuprolide Acetate or Degarelix For the Promotion of Immune Recovery Following Total Body Irradiation Based T-Cell Depleted Allogeneic Hematopoietic Stem Cell Transplantation
-
CLINICAL_TRIALS study record update · 2025-12-17A Randomized Controlled Trial Evaluating the Use of G-CSF After Plerixafor-Mobilized Autologous Stem Cell Transplant (Auto HSCT)
-
CLINICAL_TRIALS study record update · 2025-12-05Prospective Data Collection Regarding Diagnosis, Treatment and Outcome of Adult ALL Patients and Related Diseases Associated With a Prospective Collection of Biomaterial
-
CLINICAL_TRIALS study record update · 2025-12-04A Prospective, Multicenter, Randomized Controlled Trial Comparing the Efficacy and Safety of Etoposide, Cytarabine, and PEG-rhG-CSF Combination Therapy vs. Disease-Specific Chemotherapy for Hematopoietic Stem Cell Mobilization in Lymphoma
-
CLINICAL_TRIALS study record update · 2025-12-03A Phase I Trial of High Dose Therapy and Autologous Stem Cell Transplantation Followed by Infusion of Chimeric Antigen Receptor (CAR) Modified T-Cells Directed Against CD19+ B-Cells for Relapsed and Refractory Aggressive B Cell Non-Hodgkin Lymphoma
-
CLINICAL_TRIALS study record update · 2025-11-14Phase I Study of Activated T Lymphocytes Expressing Chimeric Antigen Receptors for Therapy of Relapsed CD19-Positive Malignancies Post-Allogeneic Hematopoietic Stem Cell Transplantation Infused Only After Engraftment (CARPASCIO)
-
CLINICAL_TRIALS study record update · 2025-10-22Prospective Multicenter International Observational Study for Determination of a Cutaneous Lymphoma International Prognostic Index Model and Impact of Major Therapies in Patients With Advanced Mycosis Fungoides and Sézary Syndrome
-
CLINICAL_TRIALS study record update · 2025-10-07A Randomised Platform Trial Evaluating the Role of Interventions to Prevent Infection in Patients With Acquired Hypogammaglobulinemia Secondary to Haematological Malignancies - RATIONAL-PT (Core)
-
CLINICAL_TRIALS study record update · 2025-09-08Optimized Cord Blood Transplantation for the Treatment of High-Risk Hematologic Malignancies in Adults
-
CLINICAL_TRIALS study record update · 2025-08-14Canadian-Led Immunotherapies in Cancer: CLIC-1901 for the Treatment of Patients With Relapsed/Refractory CD19 Positive Hematologic Malignancies